Interleukin (IL) 1β, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
- 7 January 1997
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (1) , 227-232
- https://doi.org/10.1073/pnas.94.1.227
Abstract
The pathophysiology of systemic inflammation and sepsis involves peripheral organs, causing gastrointestinal, renal, and cardiovascular alterations, as well as the central nervous system (CNS), affecting sleep, temperature regulation, behavior, and neuroendocrine function. The molecular basis of the CNS effects of systemic inflammation are not fully elucidated. Here we show that the CNS responds to systemic inflammation with pronounced IL-1beta gene expression and limited IL-1 receptor antagonist (IL-1ra), IL-10, and IL-13 gene expression. This pattern occurs throughout the CNS, including areas such as the subfornical organ, pineal gland, neurohypophysis, and hypothalamus. In contrast, in the anterior pituitary, we found limited IL-1beta gene expression but marked induction of the mRNA encoding for the secreted isoform of IL-1ra, secreted IL-1ra. We conclude that the central manifestations of peripheral inflammation are mediated by endogenous brain IL-1beta synthesized during systemic inflammation in the context of limited central cytokine counter regulation of IL-1. As IL-1beta is a potent stimulus for inducible nitric oxide synthase expression and activity, these findings explain our previous observation that systemic inflammation promotes inducible nitric oxide synthase gene expression in the brain and the spillover of NO metabolites into cerebrospinal fluid. The CNS transcription of the HIV-1 replication factor IL-1beta in the context of limited transcription of the IL-1 replication inhibitors IL-1ra, IL-10, and IL-13 might help explain the negative impact of systemic inflammation on the clinical course of AIDS. In addition, we propose that IL-1ra may be secreted by the anterior pituitary as a systemic anti-inflammatory hormone that is released in response to IL-1beta originated from multiple sources.Keywords
This publication has 51 references indexed in Scilit:
- IL-1β, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areasNeuroReport, 1996
- Interleukin-1β specifically stimulates nitric oxide production in the hypothalamusLife Sciences, 1996
- Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist.The Journal of Experimental Medicine, 1995
- Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient miceImmunity, 1995
- Increased Circulating Cytokines, Cytokine Antagonists, And E-Selectin After Intravenous Administration Of Endotoxin In HumansThe Journal of Infectious Diseases, 1995
- lnterleukin-1 Receptor AntagonistCritical Reviews in Immunology, 1995
- Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitroJournal of General Virology, 1994
- Cloning of Rat Interleukin-13 (IL-13) cDNA and Analysis of IL-13 Gene Expression in Experimental GlomerulonephritisBiochemical and Biophysical Research Communications, 1993
- Synthesis and characterization of rat interleukin-10 (IL-10) cDNA clones from the RNA of cultured OX8− OX22− thoracic duct T cellsBiochemical and Biophysical Research Communications, 1992
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990